BioCentury
ARTICLE | Clinical News

AnervaX therapeutic vaccine: Started Phase I trial

January 24, 1994 8:00 AM UTC

Anergen Inc. (ANRG), Redwood City, Calif. Product: AnervaX therapeutic vaccine, consisting of a short peptide of a locus in the class II major histocompatibility complex protein, to block presentation...